A 15-month-old girl with a rare genetic deletion of ten exons in the BRWD3 gene is challenging the long-held belief that XLID93 primarily manifests in males. Historically, X-linked intellectual developmental disorder-93 was viewed through a narrow lens that largely excluded female patients from the
The PandaOmics platform processes massive biological datasets, including gene expression and scientific literature, to uncover therapeutic applications that human researchers often overlook. In the current landscape of 2026, the pharmaceutical industry has transitioned from speculative
Criminals are leveraging the trust associated with digital medical platforms to execute sophisticated identity theft and financial fraud against the elderly. In recent months, Ohio has seen a sharp increase in fraudulent activity specifically targeting patients using the MyChart application, which
Most high-performance computing software suffers from diminishing returns as more processors are added, but this new architecture scales perfectly across millions of units. The pharmaceutical landscape is currently witnessing a seismic shift with the introduction of AdaptiveFlow, an open-source,
Major depressive disorder treatment currently relies on a monthslong trial-and-error process that leaves patients vulnerable while clinicians wait for signs of chemical efficacy. For decades, the standard procedure involved prescribing a medication and waiting several weeks to see if the patient
By moving beyond simple volume measurements, neurologists can now utilize network topology to categorize patients based on their specific clinical symptoms and the severity of their condition. For decades, the standard approach to diagnosing and monitoring Multiple Sclerosis concentrated on
